Study finds combination drug therapy can reduce the risk of triple-negative breast cancer spreading to other parts of the body
-
Last Update: 2020-06-10
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
researchers at the University of Missouri have now found that the combination ofdrug(http://treatment can reduce the risk of spreading triple-negative breast cancer to other parts of the body by 50 percentThe study, based on previous studies by Hyder's lab, used human metastatic cancer mice that had spread to the lungsresearchers wanted to see if two previously discovered drugs: APR-246, which restores the ability of the p53 protein to kill cancer cells, and 2aG4, which targets blood vessels to kill cancer cells, has an effect on metastatic triple-negative breast cancerBoth APR-246 and 2aG4 are currently conducting human clinicaltrial(http://The researchers hope the findings will strengthen personalized treatment for breast cancer by reducing existing cancer cells and preventing the cancer from spreading to other parts of the bodyThe study highlights the power of translational precision medicine and the prospects for the program proposed by MUThe program will bring industry partners, multiple schools and colleges on campus, as well as federal and state governments together, to make it possible totheof Precision and PersonalizedMedical(http://Mu's scientific advances will effectively translate into new drug (http:// , equipment (http:// and treatments that provide personalized patient care based on an individual's genes, environment and lifestyle, ultimately improving the and well-being of people's health (http://
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
